Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective discussions demonstrate strong endorsement and enthusiasm for the research, supported by detailed mentions of improved cardiac functions and mitochondrial benefits, as well as references to the therapeutic potential of Pan-ERR agonists, with phrases like 'significantly improved' and 'potential new therapy' highlighting their impact and relevance.
Most comments acknowledge and support the findings, emphasizing the potential benefits of Pan-ERR agonists in heart failure treatment.
Discussions consistently highlight enthusiasm for new therapies and mechanisms, reflecting high curiosity about the research.
Posts reference specific experimental results, such as improved ejection fraction and fibrosis reduction, indicating deep interest.
The majority recognize the significance of the approach, describing it as a promising therapeutic strategy that could transform treatment for heart failure.
#OriginalResearch: A novel therapeutic strategy uses Pan-ERR agonists to improve mitochondrial energetics and fatty acid metabolism and protects from pressure overload-associated heart failure @WeiyiXu9 @BCMHouston https://t.co/DLqHGTaVvU
#OriginalResearch: ERR agonists improve mitochondrial function and enhance fatty acid oxidation, which confers cardiac protection against pressure overload-induced heart failure. @WeiyiXu9 @BCMHouston https://t.co/DLqHGTaVvU
@RickyBaker_2111 @TheGenCatton https://t.co/qCIuD5pHd2 Slu pp 332 can as well. Throwing in bpc157 with dac and tb500 is just another overall winning move
RT @CircAHA: #OriginalResearch: ERR agonists improve mitochondrial function and enhance fatty acid oxidation, which confers cardiac protect…
RT @CircAHA: #OriginalResearch: A novel therapeutic strategy uses Pan-ERR agonists to improve mitochondrial energetics and fatty acid metab…
In experiments in mice, SLU-PP-332 significantly improved ejection fraction, improved fibrosis, and increased survival associated with HF caused by pressure overload without affecting cardiac hypertrophy. (https://t.co/9x7bz9viDO) #slupp332 #slupp332benefits #aasraw https://t.co/AyucKjYlci
Watch The Full Video Here httpswwwyoutubecomwatchv4JOSPiXmkwUt; Explore effective fat loss techniques using SLU-PP-332 and exercise for optimal results.
This video analyzes the molecule SLUPP332, a novel agent that enhances cardiac energy metabolism and mitochondrial function, potentially offering a safe treatment for heart failure by improving heart performance and…
This video discusses how a synthetic ERRα/β/γ agonist induces ERRα-dependent acute aerobic exercise responses and improves exercise capacity, highlighting potential applications in sports science and metabolic health.
@RickyBaker_2111 @TheGenCatton https://t.co/qCIuD5pHd2 Slu pp 332 can as well. Throwing in bpc157 with dac and tb500 is just another overall winning move
In experiments in mice, SLU-PP-332 significantly improved ejection fraction, improved fibrosis, and increased survival associated with HF caused by pressure overload without affecting cardiac hypertrophy. (https://t.co/0AWuEwH1eP) #slupp332 #slupp332benefits #aasraw https://t.co/a1ZeQ7YOx2
In experiments in mice, SLU-PP-332 significantly improved ejection fraction, improved fibrosis, and increased survival associated with HF caused by pressure overload without affecting cardiac hypertrophy. (https://t.co/9x7bz9viDO) #slupp332 #slupp332benefits #aasraw https://t.co/AyucKjYlci
RT @CircAHA: #OriginalResearch: ERR agonists improve mitochondrial function and enhance fatty acid oxidation, which confers cardiac protect…
#OriginalResearch: ERR agonists improve mitochondrial function and enhance fatty acid oxidation, which confers cardiac protection against pressure overload-induced heart failure. @WeiyiXu9 @BCMHouston https://t.co/DLqHGTaVvU
RT @CircAHA: #OriginalResearch: A novel therapeutic strategy uses Pan-ERR agonists to improve mitochondrial energetics and fatty acid metab…
RT @CircAHA: #OriginalResearch: A novel therapeutic strategy uses Pan-ERR agonists to improve mitochondrial energetics and fatty acid metab…
#OriginalResearch: A novel therapeutic strategy uses Pan-ERR agonists to improve mitochondrial energetics and fatty acid metabolism and protects from pressure overload-associated heart failure @WeiyiXu9 @BCMHouston https://t.co/DLqHGTaVvU
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function https://t.co/WSJrWP5WFF
C
DR
JH
AC
A
GR
CP